Expertise in
1
conditions

Heather E. Oakervee

St Bartholomew's Hospital
London, ENG, GB 
Expertise in
1
conditions
St Bartholomew's Hospital
London, ENG, GB 

Overview

Heather Oakervee practices practicing medicine in London, United Kingdom.

Ms. Oakervee is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Low Sodium Level, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

St Bartholomew's Hospital
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pom/Dex (Pomalidomide plus Low Dose Dexamethasone)
Study Phase: Phase 3

24 Total Publications

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 05, 2021

Frequently Asked Questions about Heather E. Oakervee

Is Heather E. Oakervee a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Heather E. Oakervee is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Heather E. Oakervee participate in research or clinical trials?

Yes. Heather E. Oakervee has published 24 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Heather E. Oakervee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Oakervee's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile